PSMA and TARP Peptide Vaccine With Poly IC-LC Adjuvant in HLA-A2 (+) Patients With Elevated PSA After Initial Definitive Treatment
Clinical trial NCT00694551 · COMPLETED
Trial details
- NCT number
- NCT00694551
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-02
- Primary completion
- 2013-02-28
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.